10-Q: Aspen Aerogels Reports Q3 Loss Amid Revenue Decline, Restructuring
Quarterly Report
Aspen Aerogels reported a significant net loss for the nine months ended September 30, 2025, driven by declining thermal barrier and energy industrial revenues and substantial impairment charges related to its Statesboro plant.
Summary
- Net loss for the nine months ended September 30, 2025, was $316.6 million, a significant decline from a net income of $2.0 million in the comparable 2024 period.
- Total revenue decreased by 30% to $229.8 million for the nine months ended September 30, 2025, compared to $329.6 million in the prior year.
- Thermal barrier revenue decreased by 35% to $152.8 million, while energy industrial revenue decreased by 17% to $76.9 million for the nine months ended September 30, 2025.
- Gross profit decreased by 49% to $68.9 million for the nine months ended September 30, 2025, from $135.8 million in the comparable 2024 period.
- Operating expenses surged to $376.8 million for the nine months ended September 30, 2025, primarily due to $287.6 million in impairment charges related to the Statesboro Plant.
- Adjusted EBITDA for the nine months ended September 30, 2025, was $20.9 million, down from $67.2 million in the comparable 2024 period.
- The company ceased construction of its second manufacturing plant in Statesboro, Georgia, in February 2025, resulting in $286.6 million in impairment charges and $16.3 million in restructuring and demobilization costs.
- Cash and cash equivalents decreased to $150.7 million as of September 30, 2025, from $220.9 million at December 31, 2024.
- The company acquired OPE Manufacturer Mexico S de RL de CV, a maquiladora assembling PyroThin products, on July 31, 2025.
Sentiment
Score: 2
Explanation: The company reported a substantial net loss, significant revenue declines across both segments, and massive impairment charges. While some cost-cutting measures are in place, the overall financial performance is very poor, and there's explicit concern about future covenant compliance and the need for additional capital.
Positives
- Net cash provided by operating activities increased to $16.7 million for the nine months ended September 30, 2025, from $9.9 million in the comparable 2024 period.
- Reduced capital expenditures to $35.0 million for the nine months ended September 30, 2025, from $71.5 million in the comparable 2024 period, following the halt of the Statesboro Plant construction.
- Successfully repurchased the $150.0 million 2022 Convertible Note in August 2024, eliminating related party interest expense.
- In compliance with financial covenants of the Amended MidCap Loan Facility as of September 30, 2025.
- Secured a $125.0 million Term Loan Facility and a $100.0 million Revolving Facility (with $26.8 million available at Sept 30, 2025) to support liquidity.
- Average selling price per square foot of energy industrial products increased by 2% for the three months ended September 30, 2025, reflecting price increases and product mix changes.
- Received a $1.1 million legal settlement payment, contributing to other income.
Negatives
- Reported a significant net loss of $316.6 million for the nine months ended September 30, 2025, compared to a net income of $2.0 million in the prior year.
- Total revenue decreased by 30% for the nine months ended September 30, 2025, driven by a 35% decline in thermal barrier revenue and a 17% decline in energy industrial revenue.
- Gross profit margin significantly declined to 30% for the nine months ended September 30, 2025, from 41% in the comparable 2024 period.
- Incurred substantial impairment charges of $286.6 million related to the Statesboro Plant and $1.0 million on R&D equipment during the nine months ended September 30, 2025.
- Restructuring and demobilization costs totaled $16.3 million for the nine months ended September 30, 2025, including severance and deferred financing costs write-off.
- Cash and cash equivalents decreased by $70.2 million from December 31, 2024, to September 30, 2025.
- Management expressed no assurance of complying with financial covenants of the Amended MidCap Loan Facility as of the end of the fourth quarter of 2025 due to declining revenues.
- EV adoption rates have been lower than originally expected, leading to re-timing of EV investments and increased downward pressure on pricing from OEM customers.
- Projecting a decline in net income and Adjusted EBITDA for the full year 2025 compared to the prior year.
Risks
- No assurance of compliance with financial covenants (Liquidity and EBITDA) of the Amended MidCap Loan Facility as of the end of the fourth quarter of 2025, which could lead to default, debt acceleration, or renegotiation on less favorable terms.
- Lenders' interests under the MidCap Loan Facility may not always align with the company's interests, potentially adversely affecting operations in case of conflict or default.
- The company expects to need to supplement its cash balance with potential equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments, or government grant and loan programs to support long-term growth.
- Equity financings could potentially result in an ownership change under Section 382 of the Internal Revenue Code, restricting the use of net operating loss carryforwards and resulting in a higher effective tax rate.
- OEM customers operate in a cyclical industry sensitive to shifting consumer trends, political/regulatory uncertainty, and economic conditions, impacting thermal barrier revenue.
- Customer cost-cutting initiatives and contractual step-downs in component pricing may result in increased downward pressure on pricing for thermal barrier products.
- Global supply chain disturbances, increased reliance on foreign materials procurement, industrial gas supply constraints, and increases in raw material costs may significantly impact material costs and operations.
- Patent enforcement actions, if protracted, could result in significant legal expenses.
- The company is subject to various legal claims and proceedings in the normal course of business, including ongoing patent infringement proceedings in Korea and a lawsuit from a former distributor (APN) seeking over $16 million in damages. The APN litigation is stayed pending arbitration.
Future Outlook
The company expects its existing cash balance to be sufficient for current operating requirements and capital expenditures for its existing business in the EV and energy industrial markets for at least the next twelve months. However, it anticipates needing to supplement its cash balance with various financings (equity, debt, leasing, sale-leaseback, customer prepayments, government grants/loans) to support its long-term growth strategy. Management projects a decline in net income and Adjusted EBITDA for the full year 2025 compared to the prior year, along with reduced capital expenditures. Both thermal barrier and energy industrial revenues are expected to decline in 2025 due to lower EV adoption rates, re-timed EV investments, customer cost-cutting, and volume declines in core energy industrial markets.
Management Comments
- "We expect that it will need to supplement its cash balance with anticipated cash flow from operations, as well as potential equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments, or government grant and loan programs to provide the additional capital necessary to support the Company’s long-term growth strategy."
- "Given the decline in our revenues in 2025 as compared to the prior year, there can be no assurance that the Company will comply with one or more of these financial covenants as of the end of the fourth quarter of 2025."
- "In response to these developments, we plan to continue our ongoing cost reduction measures, including reduced headcount, and our efforts to improve production innovation and efficiency."
- "As a result of the foregoing, we expect a decline in net income and Adjusted EBITDA during 2025 as compared to the prior year. We also expect reduced capital expenditures during 2025 as compared to the prior year."
Industry Context
The company operates in the energy industrial and electric vehicle (EV) markets, both of which are experiencing shifts. The EV market is facing lower-than-expected adoption rates in North America and Europe, leading to re-timing of investments by OEM customers and increased pressure on component pricing. This directly impacts the company's thermal barrier segment, which supplies major automotive OEMs like General Motors and Toyota. The energy industrial segment is also experiencing volume declines and project-based demand fluctuations. The company's strategy to reduce headcount and rationalize R&D programs reflects a broader industry trend of cost optimization in response to market headwinds and evolving demand.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to global benchmarks.
- It notes that OEM customers historically possess significant leverage over their outside suppliers, which is a common dynamic in the automotive supply chain.
- The decline in EV adoption rates and re-timing of EV investments are cited as industry-wide trends impacting the company's thermal barrier segment, suggesting that the company's performance is influenced by broader market conditions rather than specific competitive failures against named rivals.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer | N/A | Gregg Landes | November 4, 2025 | Promotion from Senior Vice President, Operations and Strategic Development. |
| Chief Administrative Officer, General Counsel and Corporate Secretary | N/A | Glenn Deegan | September 22, 2025 | New hire. |
| N/A | Stephanie Pittman | N/A | October 1, 2025 | Separation of employment. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Amendment | The Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan was approved by stockholders, increasing reserved shares by 3,850,000 to 16,971,994 and extending the term until April 29, 2035. | April 30, 2025 | Increases the pool of shares available for equity awards, potentially enhancing employee incentives and retention, but also increasing potential dilution. |
| New Employee Stock Purchase Plan | The Aspen Aerogels Employee Stock Purchase Plan (ESPP) was approved by stockholders, authorizing 4,000,000 shares for issuance. | April 30, 2025 | Provides eligible employees with the ability to purchase company stock at a discount, fostering employee ownership and alignment with company performance. |
| 10b5-1 Trading Plans Adoption | Donald R. Young (President & CEO) and Steven R. Mitchell (Director) adopted Rule 10b5-1 trading plans. | August 11, 2025 | Allows insiders to sell shares in a pre-arranged manner, providing an affirmative defense against insider trading allegations, but can be perceived negatively by investors if sales are substantial. |
Legal Proceedings
- Ongoing patent infringement proceedings in Korea against Beerenberg Services AS, Beerenberg Korea Ltd., and Bronx (China) Co., Ltd.
- A lawsuit from Aerogels Poland Nanotechnology LLC (APN), a former distributor, asserting claims for declaratory judgment, breach of contract, equitable estoppel, and fraud, seeking over $16 million in damages. The litigation is stayed pending arbitration.
Related Party Transactions
- Repurchased the 2022 Convertible Note from Wood River Capital, LLC (an entity affiliated with Koch Strategic Platforms, LLC) for $150.0 million on August 19, 2024.
- Settled $2.8 million in accounts payable due to a Koch affiliate for $1.2 million on March 27, 2024.
Stakeholder Impact
- Shareholders: Significant net loss and revenue decline could negatively impact share price and investor confidence. Potential future equity financings could dilute existing shareholders.
- Employees: Headcount reductions were part of the restructuring plan, indicating job losses. New hires (COO, CAO/GC/CS) and equity plan changes could impact employee morale and incentives.
- Customers: Lower contractual component prices and reduced order volumes from OEM customers in the EV market indicate pressure on customer relationships and profitability.
- Creditors (MidCap Loan Facility Lenders): The risk of non-compliance with financial covenants in Q4 2025 could lead to default, potentially impacting the company's ability to service its debt and giving lenders more control over assets.
- Suppliers: Engineering changes and cost-cutting initiatives could impact supplier relationships and demand for raw materials.
Next Steps
- Continue ongoing cost reduction measures, including headcount reductions.
- Improve production innovation and efficiency.
- Evaluate the full impact of H.R. 1 (One Big Beautiful Bill Act) on financial position, results of operations, and cash flows.
- Actively market and divest assets of the Statesboro Plant through broker-assisted sales.
- Implement new ERP software by January 2026.
- Potentially pursue equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments, or government grant and loan programs to secure additional capital for long-term growth.
- Monitor compliance with MidCap Loan Facility financial covenants, especially for Q4 2025.
- Continue to defend patent infringement proceedings in Korea and the lawsuit from Aerogels Poland Nanotechnology LLC.
Key Dates
| Date | Description |
|---|---|
| December 31, 2023 | Balance sheet date for prior year equity. |
| January 2024 | Company entered into a sale and leaseback arrangement for $5.0 million; customer notified of an engineering change to a manufactured part. |
| February 2024 | Court granted motion to compel arbitration in Aerogels Poland Nanotechnology LLC (APN) lawsuit. |
| March 5, 2024 | Compensation and Leadership Development Committee approved cancellation of unearned performance-based restricted shares. |
| March 6, 2024 | Company entered into cancellation agreements for unearned performance-based restricted shares. |
| March 27, 2024 | Company entered into a Settlement and Release Agreement with a Koch affiliate to settle accounts payable for $1.2 million. |
| June 30, 2024 | Customer approved reimbursement of $4.2 million for equipment losses related to engineering change. |
| August 19, 2024 | Company entered into Credit, Security and Guaranty Agreement (MidCap Loan Facility) and repurchased the 2022 Convertible Note for $150.0 million. |
| September 2024 | Company entered into a sale and leaseback arrangement for $10.0 million; customer approved remaining claims related to inventory obsolescence of $2.2 million. |
| December 31, 2024 | Fiscal year end for Annual Report on Form 10-K; balance sheet date for prior year. |
| February 27, 2025 | Annual Report on Form 10-K for year ended December 31, 2024, filed with SEC. |
| February 2025 | Company announced and began implementing a restructuring plan, including ceasing construction of Statesboro Plant and headcount reduction. |
| April 30, 2025 | Stockholders approved Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan and Employee Stock Purchase Plan (ESPP). |
| May 6, 2025 | Credit Agreement amended to add Aspen Georgia as a Borrower and amend the MidCap Loan Facility. |
| June 1, 2025 | First offering period for the ESPP commenced. |
| June 30, 2025 | Company implemented additional actions under restructuring plan, including headcount reduction and R&D rationalization. |
| July 4, 2025 | H.R. 1 (One Big Beautiful Bill Act) signed into law, introducing changes to U.S. federal tax provisions. |
| July 31, 2025 | Company completed the purchase of OPE Manufacturer Mexico S de RL de CV (maquiladora). |
| August 11, 2025 | Donald R. Young (President & CEO) adopted a Rule 10b5-1 Sales Plan to sell up to 100,000 shares. |
| August 12, 2025 | Steven R. Mitchell (Director) adopted a Rule 10b5-1 Sales Plan to sell up to 57,541 shares. |
| September 22, 2025 | Effective date of Executive Employment Agreement for Glenn Deegan as Chief Administrative Officer, General Counsel and Corporate Secretary. |
| September 30, 2025 | End of the quarterly period covered by this report; balance sheet date. |
| October 1, 2025 | Separation Date for Stephanie Pittman. |
| November 4, 2025 | Gregg Landes promoted to Chief Operating Officer; shares of common stock outstanding reported as 82,647,081. |
| November 6, 2025 | Date of issuance of the consolidated financial statements and filing date of this 10-Q. |
| November 15, 2025 | Deadline for Stephanie Pittman to sign the Separation and Release Agreement. |
| November 30, 2025 | End of the first offering period for the ESPP. |
| December 1, 2025 | Second offering period for the ESPP commences. |
| December 31, 2025 | End date for Donald R. Young's 10b5-1 Sales Plan; next test date for minimum EBITDA covenant ($15 million). |
| January 2026 | Updated implementation date for new ERP software. |
| May 31, 2026 | End of the second offering period for the ESPP. |
| November 12, 2026 | End date for Steven R. Mitchell's 10b5-1 Sales Plan. |
| December 31, 2027 | End of three-year performance period for Glenn Deegan's PSUs; minimum EBITDA covenant level increases to $50 million. |
| March 5, 2028 | Vesting date for Glenn Deegan's PSUs. |
| August 19, 2029 | Maturity date for MidCap Loan Facility. |
| April 29, 2035 | Extended term of the 2023 Equity Incentive Plan. |
Recommendation
strong sellThe company reported a massive net loss of $316.6 million for the nine months, primarily due to a $287.6 million impairment charge from abandoning its Statesboro plant. Revenue declined significantly by 30%, and Adjusted EBITDA plummeted by 69%. Management explicitly stated there's "no assurance" of complying with debt covenants in Q4 2025, signaling severe financial distress and potential default. The need for future capital raises, coupled with declining market demand in key segments (EV and energy industrial), paints a grim picture. The 10b5-1 plans by the CEO and a director to sell shares further indicate a lack of confidence. These factors collectively point to substantial downside risk and a highly unfavorable investment outlook.
Keywords
Aerogel technology, Thermal barriers, Electric vehicles (EV), Energy industrial, PyroThin, Cryogel, Pyrogel, SEC filing, 10-Q, Financial results, Restructuring, Impairment charges, Liquidity, Debt covenants, Corporate governance, Management changes, Stock-based compensation, Supply chain, Market risk, Patent infringement, Capital expenditures, Revenue decline, Net loss, Adjusted EBITDA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.